Health Care & Life Sciences » Healthcare Provision | Sapporo Clinical Laboratory Inc.

Sapporo Clinical Laboratory Inc. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
853
896
950
746
1,052
Depreciation, Depletion & Amortization
339
334
303
334
342
Other Funds
229
405
255
315
188
Funds from Operations
963
825
998
765
1,207
Changes in Working Capital
48
216
57
96
104
Net Operating Cash Flow
915
610
942
670
1,310
Capital Expenditures
233
415
503
560
316
Sale of Fixed Assets & Businesses
-
-
49
1
25
Purchase/Sale of Investments
1
1
20
1
1
Net Investing Cash Flow
242
449
455
530
293
Cash Dividends Paid - Total
44
44
42
38
35
Issuance/Reduction of Debt, Net
61
46
41
35
28
Net Financing Cash Flow
105
496
83
74
95
Net Change in Cash
568
335
404
66
922
Free Cash Flow
685
296
468
124
1,010
Other Sources
5
5
19
30
3
Change in Capital Stock
-
406
-
-
32
Other Uses
14
39
-
-
5

About Sapporo Clinical Laboratory

View Profile
Address
18-9-1 Nishi, Kita 5-Jo
Sapporo Hokkaido 060
Japan
Employees -
Website http://www.saturin.co.jp
Updated 09/14/2018
Sapporo Clinical Laboratory Inc. engages in the clinical testing business for the medical industry. It operates through the following segments: Clinical Testing, Dispensing Pharmacy, Medical Equipment Sales and Maintenance, and Others. The Clinical Testing segment provides contract laboratory tests necessary for medical institutions.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.